Deep knowledge on
small-molecule drugs and
the 90,000 global patents
|Title:||Rectally-administered, epileptic-seizure-inhibiting composition|
|Abstract:||This invention provides a rectally administered composition for inhibiting epileptic seizure and to its methods of use. The composition contains, in a suitable solvent, an anti-epileptic agent for inhibiting epileptic seizure, a buffer for maintaining pH, and a thickener for imparting a viscosity to the composition effective for rectal administration by injection to a patient in epileptic seizure.|
|Inventor(s):||Evenstad; Kenneth L. (Wayzata, MN), O'Neill; Victoria A. (Wayzata, MN), Gorham; Thomas R. (Brooklyn Park, MN)|
|Assignee:||Athena Neurosciences, Inc. (San Francisco, CA)|
Patent Claim Types:|
see list of patent claims
|Country||Document Number||Publication Date||Supplementary Protection Certificate||SPC Country||SPC Expiration|
|Canada||2171627||Jan 31, 2006|
|Australia||7686394||Apr 03, 1995|
|World Intellectual Property Organization (WIPO)||9507672||Mar 23, 1995|
|Canada||2171627||Mar 23, 1995|
|This preview shows a limited data set|
Subscribe for full access, or try a free trial
Export unavailable in trial.
Subscribe for complete access.
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors.
Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided information. There is no warranty that the information contained herein is error free. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.